Mukherjee A, Biswas S, Roy I
Acta Pharmacol Sin. 2025; .
PMID: 39890942
DOI: 10.1038/s41401-024-01455-w.
Wang S, Meng Z, Zhang Y, Yan Y, Li L
Front Neurol. 2024; 15:1392984.
PMID: 39050130
PMC: 11266091.
DOI: 10.3389/fneur.2024.1392984.
Liu F, Lu W, Liu L
Front Mol Neurosci. 2024; 17:1324702.
PMID: 38500676
PMC: 10944861.
DOI: 10.3389/fnmol.2024.1324702.
Guadagno A, Medina S
Pept Sci (Hoboken). 2023; 115(2).
PMID: 37153755
PMC: 10162500.
DOI: 10.1002/pep2.24303.
Triller G, Garyfallos D, Papavasiliou F, Sklaviadis T, Stavropoulos P, Xanthopoulos K
Int J Mol Sci. 2022; 23(18).
PMID: 36142526
PMC: 9503410.
DOI: 10.3390/ijms231810629.
Treatment of microglia with Anti-PrP monoclonal antibodies induces neuronal apoptosis .
Adhikari U, Sakiz E, Habiba U, Mikhael M, Senesi M, David M
Heliyon. 2022; 7(12):e08644.
PMID: 35005289
PMC: 8715334.
DOI: 10.1016/j.heliyon.2021.e08644.
Epitope-specific anti-PrP antibody toxicity: a comparative study of human and mouse prion proteins.
Adhikari U, Tayebi M
Prion. 2021; 15(1):155-176.
PMID: 34632945
PMC: 8900626.
DOI: 10.1080/19336896.2021.1964326.
Cross-Linking Cellular Prion Protein Induces Neuronal Type 2-Like Hypersensitivity.
Adhikari U, Sakiz E, Zhou X, Habiba U, Kumar S, Mikhael M
Front Immunol. 2021; 12:639008.
PMID: 34394070
PMC: 8361482.
DOI: 10.3389/fimmu.2021.639008.
Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer's Mouse Model With Tau Pathology.
Boutajangout A, Zhang W, Kim J, Abdali W, Prelli F, Wisniewski T
Front Aging Neurosci. 2021; 13:640677.
PMID: 33716717
PMC: 7947695.
DOI: 10.3389/fnagi.2021.640677.
Immunotherapy against Prion Disease.
Ma Y, Ma J
Pathogens. 2020; 9(3).
PMID: 32183309
PMC: 7157205.
DOI: 10.3390/pathogens9030216.
Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson's Disease.
Shen N, Song G, Yang H, Lin X, Brown B, Hong Y
Int J Mol Sci. 2019; 20(9).
PMID: 31083520
PMC: 6539124.
DOI: 10.3390/ijms20092338.
Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.
Charco J, Erana H, Venegas V, Garcia-Martinez S, Lopez-Moreno R, Gonzalez-Miranda E
Pathogens. 2017; 6(4).
PMID: 29240682
PMC: 5750591.
DOI: 10.3390/pathogens6040067.
Induction of PrP-specific systemic and mucosal immune responses in white-tailed deer with an oral vaccine for chronic wasting disease.
Taschuk R, Scruten E, Woodbury M, Cashman N, Potter A, Griebel P
Prion. 2017; 11(5):368-380.
PMID: 28968152
PMC: 5639826.
DOI: 10.1080/19336896.2017.1367083.
Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo.
Diaz-Espinoza R, Morales R, Concha-Marambio L, Moreno-Gonzalez I, Moda F, Soto C
Mol Psychiatry. 2017; 23(3):777-788.
PMID: 28630454
PMC: 5738294.
DOI: 10.1038/mp.2017.84.
Recombinant Antibody Fragments for Neurodegenerative Diseases.
Manoutcharian K, Perez-Garmendia R, Gevorkian G
Curr Neuropharmacol. 2016; 15(5):779-788.
PMID: 27697033
PMC: 5771054.
DOI: 10.2174/1570159X01666160930121647.
Differential Toxicity of Antibodies to the Prion Protein.
Reimann R, Sonati T, Hornemann S, Herrmann U, Arand M, Hawke S
PLoS Pathog. 2016; 12(1):e1005401.
PMID: 26821311
PMC: 4731068.
DOI: 10.1371/journal.ppat.1005401.
In vitro neutralization of prions with PrP(Sc)-specific antibodies.
Taschuk R, van der Merwe J, Marciniuk K, Potter A, Cashman N, Griebel P
Prion. 2015; 9(4):292-303.
PMID: 26284508
PMC: 4601508.
DOI: 10.1080/19336896.2015.1071761.
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Mandler M, Valera E, Rockenstein E, Mante M, Weninger H, Patrick C
Mol Neurodegener. 2015; 10:10.
PMID: 25886309
PMC: 4411775.
DOI: 10.1186/s13024-015-0008-9.
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.
Mandler M, Valera E, Rockenstein E, Weninger H, Patrick C, Adame A
Acta Neuropathol. 2014; 127(6):861-79.
PMID: 24525765
PMC: 4034750.
DOI: 10.1007/s00401-014-1256-4.
Safety, specificity and immunogenicity of a PrP(Sc)-specific prion vaccine based on the YYR disease specific epitope.
Taschuk R, Marciniuk K, Maattanen P, Madampage C, Hedlin P, Potter A
Prion. 2014; 8(1):51-9.
PMID: 24509522
PMC: 7030909.
DOI: 10.4161/pri.27962.